Journal
BIOMEDICAL CHROMATOGRAPHY
Volume 15, Issue 5, Pages 295-318Publisher
WILEY
DOI: 10.1002/bmc.75
Keywords
-
Ask authors/readers for more resources
Fluorogenic and fluorescent labeling reagents having a benzofurazan (2,1,3-benzoxadiazole) skeleton such as 4-fluoro-7-nitro-2,1,3-benzoxadiazole (NBD-F), 4-NN-dimethylan-linosulfonyl-7-fluoro-2,1.3-benzoxadiazole (DBD-F), 4-aminosulfonyl-7fluoro-2,1,3-benzoxadiazole (ABD-F), ammonium 7-fluoro-2,1,3-benzoxadiazole-4-sulfonate (SBD-F), 4-hydrazino-7-nitro-2,1,3,benzoxadiazole (NBD-H), 4-NN-dimethylaminosulfonyl-7-hydrazino-2,1,3-benzoxadiazole (DBD-H), 4-nitro-7-N-piperazino2,1,3-benzoxadiazole (NBD-PZ), 4-NN-dimethylaminosulfonyl-7-N-piperazino-2,1,3-benzoxadiazole (DBD-PZ), 4-(N-chloroformylmethyl-N-methyl)amino-7-N,N-dimethylaminosulfonyl-2,1,3-benzoxadiazole (DBD-COCI) and 7-NN-dimethylaniinosulfonyl4-(2,1,3-benzoxadiazolyl) isothiocyanate (DBD-NCS) are reviewed in terms of synthetic method, reactivity, fluorescence characteristics. sensitivity and application to analytes. Copyright (C) 2001 John Wiley & Sons, Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available